Evolent Health, Inc.
EVH
$4.20
$0.000.00%
NYSE
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 7.92% | -8.13% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 7.92% | -8.13% | |||
| Cost of Revenue | 10.41% | -9.77% | |||
| Gross Profit | -0.61% | -2.04% | |||
| SG&A Expenses | 1.46% | -2.99% | |||
| Depreciation & Amortization | 2.05% | -3.81% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 8.46% | -8.39% | |||
| Operating Income | -76.72% | 65.85% | |||
| Income Before Tax | 3.69% | 67.19% | |||
| Income Tax Expenses | 209.82% | -156.12% | |||
| Earnings from Continuing Operations | -4.86% | 69.21% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -4.86% | 69.21% | |||
| EBIT | -76.72% | 65.85% | |||
| EBITDA | -8.32% | 4.65% | |||
| EPS Basic | 46.45% | 29.62% | |||
| Normalized Basic EPS | -92.09% | 87.14% | |||
| EPS Diluted | 46.45% | 29.62% | |||
| Normalized Diluted EPS | -92.09% | 87.14% | |||
| Average Basic Shares Outstanding | -1.57% | 0.49% | |||
| Average Diluted Shares Outstanding | -1.57% | 0.49% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | 0.60% | -2.28% | |||